ArticleOxford medical case reports2026

Selective cTACE to a segment target hepatocellular carcinoma lesion during atezolizumab plus bevacizumab therapy achieving delayed hypovascularization and shrinkage of non-target intrahepatic lesions: a case report.

Hidenobu Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.